These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28139625)
21. [Characteristics of the regulation of neurotrophic mechanisms in ischemic stroke]. Tsygan NV; Trashkov AP; Yakovleva VA; Malkova VM; Gracheva EV; Kovalenko AL; Vasiliev AG Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):112-116. PubMed ID: 26356524 [TBL] [Abstract][Full Text] [Related]
22. [The efficacy of cytoflavin in the treatment of burnout syndrome]. Chutko LS; Surushkina SY; Yakovenko EA; Rozhkova AV; Anisimova TI; Bondarchuk YL Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):66-70. PubMed ID: 26525625 [TBL] [Abstract][Full Text] [Related]
23. [The preventive treatment of stroke in patients with discirculatory encephalopathy with a depressive syndrome]. Erkebaeva SK; Nurguzhaev ES; Gafurov BG; Tuksanbaeva GU Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):32-6. PubMed ID: 23257743 [TBL] [Abstract][Full Text] [Related]
24. [Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction]. Chichanovskaia LV; Tsukurova LA; Kovalenko AL; Nazarov MV; Lukin DI; Rumiantseva SA; Silina EV; Stupin VA; Nedorostkova TIu; Kabaeva EN; Eliseev EV Eksp Klin Farmakol; 2015; 78(1):21-6. PubMed ID: 25826870 [TBL] [Abstract][Full Text] [Related]
25. [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Suslina ZA; Klocheva EG; Piradov MA; Rumiantseva SA; Romantsov MG; Kovalenko AL Klin Med (Mosk); 2010; 88(3):50-3. PubMed ID: 20608066 [TBL] [Abstract][Full Text] [Related]
26. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy]. Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423 [TBL] [Abstract][Full Text] [Related]
27. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis]. Kosinets VA Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286 [TBL] [Abstract][Full Text] [Related]
28. [The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin]. Kartashova EA; Romantsov MG; Sarvilina IV Adv Gerontol; 2014; 27(4):737-45. PubMed ID: 25946853 [TBL] [Abstract][Full Text] [Related]
29. [Cytoflavin in the detoxification of alcohol-dependent patients]. Minko AI; Linskiĭ IV; Kuz'minov VN; Samoĭlova ES; Goloshchapov VV; Artemchuk KA Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):35-40. PubMed ID: 23887449 [TBL] [Abstract][Full Text] [Related]
30. [Efficiency of cytoflavin in the treatment of somatoform disorders]. Chutko LS; Surushkina SY; Yakovenko EA; Anisimova TI; Prokopenko SM Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):21-24. PubMed ID: 28252599 [TBL] [Abstract][Full Text] [Related]
31. [The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia]. Drozd OA; Efremov VV; Dudarev IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):46-9. PubMed ID: 23528494 [No Abstract] [Full Text] [Related]
32. [Cytoflavin in polychemotherapy of breast cancer]. Kashuro VA; Glushkov SI; Zheregelia SN Antibiot Khimioter; 2010; 55(7-8):30-3. PubMed ID: 21140562 [TBL] [Abstract][Full Text] [Related]
33. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency]. Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033 [TBL] [Abstract][Full Text] [Related]
34. [THE EFFECT OF CYTOFLAVIN ON PARAMETERS OF THE LEFT VENTRICULAR SYSTOLIC FUNCTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION.]. Pereverzev DI; Simonova NV; Dorovskikh VA; Anokhina RA Eksp Klin Farmakol; 2017; 80(1):14-17. PubMed ID: 29873997 [TBL] [Abstract][Full Text] [Related]
35. [Therapeutic possibilities of improvement of cognitive functions, psychoemotional condition and a quality of life in post-stroke patients]. Kovalchuk VV Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):92-97. PubMed ID: 26978500 [TBL] [Abstract][Full Text] [Related]
36. [Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury]. Skoromets AA; Pugacheva EL Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):31-6. PubMed ID: 20517223 [TBL] [Abstract][Full Text] [Related]
38. [The use of cytoflavin in the complex treatment of patients with tick-borne encephalitis]. Selezneva AG; Petrova AG Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7):68-9. PubMed ID: 23011438 [No Abstract] [Full Text] [Related]
39. [Improvement of speech discrimination with cytoflavin in patients with chronic sensorineural deafness]. Zhuravskiĭ SG Vestn Otorinolaringol; 2010; (4):82-6. PubMed ID: 21105353 [No Abstract] [Full Text] [Related]
40. [Substantiation of the drug «Cytoflavin» application and cognitive-behavioral therapy in complex treatment of deforming coxarthrosis in elderly patients.]. Zakharov IK; Belov VG; Parfyonov UA; Parfyonov SA; Ershov EV; Sapozhnikov KV; Zaplutanov VA Adv Gerontol; 2019; 32(3):439-444. PubMed ID: 31512432 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]